Cutting Edge Science, Cellular Level Healing
Scientifically proven to outperform prescription antidepressants
Delivered in the privacy, safety, and convenience of your own home
Now available to Gift
How our Technology Works
-
Treating the Root Cause
We focus on treating brain regions which are proven to be underactive in patients diagnosed with depression
-
Medication-Free Technology
We gently stimulate brain cells with a small amount of electrical energy in order to restore their function
-
Medical Innovation
The treatments have been developed in the NHS and leading neuroscience institutes around the world
-
Scientifically Proven
Studies from the leading medical journals show that treatment is upto twice as effective as antidepressants
Feel Better in Three Weeks
-
Treating the Root Cause
We focus on treating brain regions which are proven to be underactive in patients diagnosed with depression
-
Medication-Free Technology
We gently stimulate brain cells with a small amount of electrical energy in order to restore their function
-
Medical Innovation
The treatments have been developed in the NHS and leading neuroscience institutes around the world
-
Scientifically Proven
Studies from the leading medical journals show that treatment is upto twice as effective as antidepressants
Unparalleled Safety and Quality
-
Treating the Root Cause
We focus on treating brain regions which are proven to be underactive in patients diagnosed with depression
-
Medication-Free Technology
We gently stimulate brain cells with a small amount of electrical energy in order to restore their function
-
Medical Innovation
The treatments have been developed in the NHS and leading neuroscience institutes around the world
-
Scientifically Proven
Studies from the leading medical journals show that treatment is upto twice as effective as antidepressants
What You Get
-
Treating the Root Cause
We focus on treating brain regions which are proven to be underactive in patients diagnosed with depression
-
Medication-Free Technology
We gently stimulate brain cells with a small amount of electrical energy in order to restore their function
-
Medical Innovation
The treatments have been developed in the NHS and leading neuroscience institutes around the world
-
Scientifically Proven
Studies from the leading medical journals show that treatment is upto twice as effective as antidepressants
What you get
Treating the Root Cause
The Dorsolateral PreFrontal Cortex (DLPFC) brain region plays a key role in depression because it connects to parts of the brain that control mood, like the amygdala and anterior cingulate. In depression, the DLPFC is underactive, which disrupts these mood circuits. Treatments like psychotherapy, medication, or transcranial magnetic stimulation (TMS) can affect the DLPFC, however using our TCDS technology to stimulate the area directly, we can restore its activity and help fix these connections. This improves mood and treats the root causes of depression effectively.
Medication-Free Technology
The wearable headset, in conjunction with the targeted nutritional support, gently stimulates and repairs targeted brain cells to restore their function. Initially, a personalised programme is used to activate brain regions over a number of weeks. Treatment then switches to a strengthening phase to provide long-lasting results.
During tDCS, most people will feel a mild tingling, prickling, itching, or warmth. These sensations are not painful and go away when stimulation stops. Each week you may require between two and five half-hour sessions and complete courses typically last three months in the comfort and convenience of your own home.
Medical Innovation
tCDS treatment is offered to NHS clinicians, such as doctors who suffer from depression, nationwide through the NHS Practitioner Health Programme.
tCDS is also offered to NHS patients in NHS trusts across Northamptonshire, Leicestershire and West London. Every NHS service using tCDS has independently published their findings that demonstrate Flow is safe and effective to use.
The Leicestershire NHS Partnership Trust Crisis Service has shown up to a 75% drop in suicidal ideation across the trial leading to a decrease in hospital admissions.
Scientifically Proven
There are now over twenty large high-quality Randomised Control Trials (RCTs) involving thousands of patients showing Class A evidence that tCDS has a definite effect on significantly treating depression.
The largest UK study in tCDS was published in October 2024 in Nature Medicine (ranked third amongst all primary research journals in the world). It showed that patients completing ten weeks of tDCS were twice as likely to experience remission from their depression than control groups.
Additional Benefits
As well as documented improvements in mood, the clinical trial showed that additional benefits of the therapy resulted in better sleep (+25%), focus (+25%), control of anxiety (+31%), zest for life (+32%) and emotional imvovement (+35%).
Testimonials